COLUMBUS , Ohio – New research shows that a wasting condition responsible for nearly a third of all cancer deaths involves the loss of an essential muscle protein that is also lost in people with ...

Duchenne muscular dystrophy is a severe and progressive disorder caused by mutations in the dystrophin (DMD) gene that lead to malfunction or absence of dystrophin. This protein stabilizes the ...

The US Food and Drug Administration (FDA) has delayed a ruling on Sarepta Therapeutics’ Biologics License Application for SRP-9001, a gene therapy for ambulatory patients with Duchenne muscular ...

Muscle contraction is the tightening, shortening, or lengthening of muscles when you do some activity. It can happen when you hold or pick up something, or when you stretch or exercise with weights.

Duchenne muscular dystrophy (DMD) is a genetic disease that causes progressive muscle weakness. DMD commonly affects boys, where symptoms are seen in early childhood. There is currently no cure for ...

On Tuesday, Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping ...

Conceptual paper illustration of human hands and DNA in a lab. Senior Correspondent For genetic conditions like Duchenne muscular dystrophy, there is little doctors can do to slow or treat the ...

Panel A shows the structure of dystrophin, including its four hinge domains and 24 spectrin-like domains, flanked by the N-terminal domain in red, the cysteine-rich domain in yellow, and the ...

On Tuesday, Dyne Therapeutics Inc. (NASDAQ:DYN) announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 ...

The flow of water within a muscle fiber may dictate how quickly muscle can contract, according to a new study. The flow of water within a muscle fiber may dictate how quickly muscle can contract, ...